The use of hyperimmune chicken reference sera is not appropriate for the validation of influenza pseudotype neutralization assays
F. Ferrara, E. Molesti, S. Scott, G. Cattoli, N. J. Temperton
Abstract
Pseudotype particle neutralization (pp-NT) is a next-generation serological assay employed for the sensitive study of influenza antibody responses, especially haemagglutinin stalk-directed antibodies. However, to date a validation of this assay has not been performed, and this limits its use to primarily research laboratories. To identify possible serological standards to be used in optimization and validation of the pp-NT, we have evaluated the cross-reactivity of hyperimmune chicken reference antisera in this assay. Our findings show that the cross-reactivity detected by the pp-NT assay is only in part explained by phylogenetic relationships and protein homology between the HA subtypes analysed; further studies are necessary to understand the origin of the cross-reactivity detected, and reference standards with higher specificity should be evaluated or generated de novo for future use in pp-NT.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Establishment of pan-Influenza A (H1-H18) and pan-Influenza B (pre-split, Vic/Yam) Pseudotype Libraries for efficient vaccine antigen selection
J. M. Del Rosario, K. da Costa, … N. J. Temperton·bioRxiv·May 20, 2021
- The study of antibody responses to influenza neuraminidase using a lentiviral pseudotype based ELLA
Fabrizio Biuso, George Carnell, … Nigel Temperton·bioRxiv·Nov 13, 2017
- Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design
K. A. S. da Costa, J. M. M. Del Rosario, … N. J. Temperton·bioRxiv·Sep 19, 2021
- Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studies
Francesca Ferrara, George Carnell, … Nigel J Temperton·bioRxiv·Dec 10, 2018
- Impact of serum versus anticoagulant-containing plasma on influenza virusneuraminidase-based serological assays
Thi Hoai Thu Do, Stephen John Kent, … Marios Koutsakos·VaccinePeer-reviewed·Nov 13, 2025
- Development of hybrid alphavirus-influenza A, B, and D pseudovirions for rapid quantification of neutralization antibodies and antiviral drugs
Brian Hetrick, Dongyang Yu, … Yuntao Wu·bioRxiv·Mar 4, 2026